Deep vein thrombosis in pregnant women with heterozygous factor-V Leiden mutation: a case report

İyad Fansa,

İyad Fansa¹, Arif Güngören², Ali Ulvi Hakverdi², Şahin Zeteroğlu², Çağcıl Yetim²

¹Department of Cardiovascular Surgery, Medicine Faculty of Mustafa Kemal University, Antakya
²Department of Obstetrics and Gynecology, Medicine Faculty of Mustafa Kemal University, Antakya

Deep vein thrombosis during pregnancy is an important risk factor increasing maternal morbidity and mortality. Factor V Leiden mutation is the most frequent one among many hereditary and acquired thrombophilic risk factors during pregnancy. In a 23-year-old woman who had been pregnant for 11 weeks and applied to hospital with sudden onset pain, swelling, and erythema in her left lower extremity, a thrombus from left main iliac to superficial femoral veins was detected via Doppler ultrasonography. She was hospitalized and low molecular-weight heparin (enoxaprine sodium) was initiated with a dosage of 12000 IU/day. She showed a rapid healing clinically and was followed up with enoxaprine and varsity sock until delivery. After labor, the dosage of enoxaprine was halved and withdrawn after six weeks, and oral warfarin sodium was started. The patient is still continued to be followed up without any problems.

Keywords : Deep vein thrombosis; enoxaprine; factor V Leiden mutation; pregnancy

Viewed : 9900

Downloaded : 3198